The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ARCT FINANCIAL STATEMENTS

Arcturus Therapeutics Holdings Inc — balance sheet, income statement and cash flow trends

ARCTArcturus Therapeutics Holdings Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue23.8 M $Gross Profit19.8 M $ · 83%Operating Income-103.1 M $ · -433%Pre-tax Income-93.3 M $ · -392%Net Income to Owners-93.3 M $ · -392%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue23.8 M $-79.1%
Gross Profit19.8 M $-82.6%
Operating Income-103.1 M $—
EBITDA-82.9 M $—
Net Income to Owners-93.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets224.3 M
  • Equity171.8 M $77%
  • Current Liabilities33.5 M $15%
  • Long-term Liabilities19 M $8%

Key Figures

YoY change
Total Assets224.3 M $-27.5%
Total Liabilities52.5 M $-32.9%
Total Equity171.8 M $-25.6%
Cash & ST Investments191.5 M $-2.5%
Total Debt22.9 M $-14.9%
Net Debt-168.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-50 M0-92.2 M $Operating-7.7 K $Investing12.9 M $Financing-79.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-92.2 M $—
Capital Expenditures318.7 K $+45.2%
Free Cash Flow-92.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ARCT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.